The year in cardiovascular medicine 2021: diabetes and metabolic disorders.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34974614.
- Also identified by DOI 10.1093/eurheartj/ehab876.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the current paper, we review recently published studies that are helping us to understand how the treatment landscape for glucagon-like peptiide-1 receptor agonists and sodium glucose cotransporter 2 inhibitors is moving forward. We have also included relevant articles related to cardiovascular disease prevention in the setting of obesity, atherogenic dyslipidaemia and chronic kidney disease.
Medical subject headings
- Cardiovascular Agents
- Cardiovascular Diseases
- Diabetes Mellitus, Type 2
- Renal Insufficiency, Chronic
- Sodium-Glucose Transporter 2 Inhibitors